|4Feb 11, 5:02 PM ET

Arbet-Engels Christophe 4

4 · Millendo Therapeutics, Inc. · Filed Feb 11, 2020

Insider Transaction Report

Form 4
Period: 2020-02-10
Arbet-Engels Christophe
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-02-10+140,000140,000 total
    Exercise: $6.90Exp: 2030-02-09Common Stock (140,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to this option shall vest on February 10, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the recipient continuing to provide service through that date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION